PACTR202310814099421

The effect of two varying doses of intravenous tranexamic acid on blood loss after vaginal delivery at term in University of Benin Teaching Hospital

The effect of two varying doses of intravenous tranexamic acid on blood loss after vaginal delivery at term in University of Benin Teaching Hospital: a double-blinded randomized placebo controlled trial
Centre for excellence in reproductive health initiative·Not Applicable·Pan Africa Clinical Trials Registry·drugRecruitment Completed
Study focus
Disease/Condition
Obstetrics and Gynecology
Intervention type
drug
Sponsor & location
Primary sponsor
Centre for excellence in reproductive health initiative
Funder
Michael Osahumen Orhue
Location
Nigeria
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

Primary postpartum haemorrhage is a common cause of maternal mortality especially in third world countries where there is relative lack of blood transfusion services, coupled with the high prevalence of anaemia in pregnancy which makes women in these settings more prone to adverse outcome from PPH. this underscores the need to explore other innovative strategies for the prevention of PPH in addition to the active management of third stage labour recommended by the World Health Organization. Tranexamic acid is currently recommended in the management of PPH. however, its role in the prevention of PPH is still being studied. this study seeks to explore the effect of tranexamic acid on reducing blood loss following vaginal delivery as a surrogate for the prevention of PPH.

ICD-10 classifications
Obstetric and gynaecological devices associated with adverse incidentsObstructed labour due to other maternal pelvic abnormalitiesObstetric and gynaecological devices associated with adverse incidents : miscellaneous devices, not elsewhere classifiedObstetric and gynaecological devices associated with adverse incidents : diagnostic and monitoring devicesOther complications of obstetric surgery and procedures
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202310814099421
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202310814099421 through Pure Global AI's free database. This Not Applicable trial is sponsored by Centre for excellence in reproductive health initiative and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.